Nutex Health Investors: Lead the Fight Against Alleged Securities Fraud

In a significant development for shareholders, investors in Nutex Health Inc. (NASDAQ: NUTX) who incurred losses during a crucial period are now presented with a pivotal opportunity to lead a securities fraud class action lawsuit. This legal action aims to hold the company accountable for alleged misleading statements, offering a path for affected investors to potentially recover their losses.

The lawsuit focuses on the period between February 22, 2022, and August 16, 2022.

During this time, it is alleged that Nutex Health, a company specializing in micro-hospitals and freestanding emergency rooms, made materially false and/or misleading statements to the public. These statements purportedly misrepresented the company's financial health, business trajectory, and operational capabilities, particularly in relation to its highly publicized acquisition of Physicians Premier ER.

Specifically, the complaint alleges that Nutex Health failed to disclose critical adverse facts concerning its business, operations, and prospects.

These undisclosed issues included significant deficiencies in the company's internal controls over financial reporting. Such omissions and misrepresentations are believed to have artificially inflated Nutex Health’s stock price, creating a deceptive picture for investors.

The truth began to surface after the close of the market on August 16, 2022.

On this date, Nutex Health revealed in a Form 8-K filing that its previously issued unaudited interim financial statements for the three months ended March 31, 2022, should no longer be relied upon. The company admitted to a material weakness in its internal control over financial reporting, specifically related to the accounting for its acquisition of Physicians Premier ER.

This stunning revelation sent shockwaves through the market, causing Nutex Health's stock to plummet by over 32% in after-hours trading, severely impacting investors.

Investors who purchased Nutex Health securities during the aforementioned class period and suffered losses are strongly encouraged to come forward.

The deadline to file a motion to be appointed as the lead plaintiff is December 26, 2022. Becoming a lead plaintiff allows an investor to direct the litigation and play a vital role in the recovery efforts for all class members. While participation isn't mandatory to recover, leading the lawsuit empowers you to guide the legal strategy.

The Schall Law Firm, a leading investor rights law firm, is actively investigating claims against Nutex Health Inc.

and is encouraging affected shareholders to contact them to discuss their legal options. There is no cost or obligation for a consultation. This is a critical moment for investors to assert their rights and seek redress for alleged corporate misdeeds. Don't miss this opportunity to potentially recover your investment and ensure accountability.